560 related articles for article (PubMed ID: 23893685)
1. G-protein-coupled designer receptors - new chemical-genetic tools for signal transduction research.
Thiel G; Kaufmann A; Rössler OG
Biol Chem; 2013 Dec; 394(12):1615-22. PubMed ID: 23893685
[TBL] [Abstract][Full Text] [Related]
2. DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility.
Urban DJ; Roth BL
Annu Rev Pharmacol Toxicol; 2015; 55():399-417. PubMed ID: 25292433
[TBL] [Abstract][Full Text] [Related]
3. Engineering GPCR signaling pathways with RASSLs.
Conklin BR; Hsiao EC; Claeysen S; Dumuis A; Srinivasan S; Forsayeth JR; Guettier JM; Chang WC; Pei Y; McCarthy KD; Nissenson RA; Wess J; Bockaert J; Roth BL
Nat Methods; 2008 Aug; 5(8):673-8. PubMed ID: 18668035
[TBL] [Abstract][Full Text] [Related]
4. Ligand screening system using fusion proteins of G protein-coupled receptors with G protein alpha subunits.
Suga H; Haga T
Neurochem Int; 2007; 51(2-4):140-64. PubMed ID: 17659814
[TBL] [Abstract][Full Text] [Related]
5. Novel designer receptors to probe GPCR signaling and physiology.
Wess J; Nakajima K; Jain S
Trends Pharmacol Sci; 2013 Jul; 34(7):385-92. PubMed ID: 23769625
[TBL] [Abstract][Full Text] [Related]
6. Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands.
Goetzl EJ
FASEB J; 2007 Mar; 21(3):638-42. PubMed ID: 17194692
[TBL] [Abstract][Full Text] [Related]
7. Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs.
Hsu SH; Luo CW
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1021-9. PubMed ID: 17652154
[TBL] [Abstract][Full Text] [Related]
8. Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors.
Masuho I; Ostrovskaya O; Kramer GM; Jones CD; Xie K; Martemyanov KA
Sci Signal; 2015 Dec; 8(405):ra123. PubMed ID: 26628681
[TBL] [Abstract][Full Text] [Related]
9. Utilizing Designed Receptors Exclusively Activated by Designer Drug Chemogenetic Tools to Identify Beneficial G Protein-Coupled Receptor Signaling for Fibrosis.
Zhang J; Vardy E; Muise ES; Wang TM; Visconti R; Vadlamudi A; Pinto S; Peier AM
J Pharmacol Exp Ther; 2020 Nov; 375(2):357-366. PubMed ID: 32848074
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
Kristiansen K
Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
[TBL] [Abstract][Full Text] [Related]
11. Use of Designer G Protein-Coupled Receptors to Dissect Metabolic Pathways.
Wess J
Trends Endocrinol Metab; 2016 Sep; 27(9):600-603. PubMed ID: 27381463
[TBL] [Abstract][Full Text] [Related]
12. Fusion proteins as model systems for the analysis of constitutive GPCR activity.
Schneider EH; Seifert R
Methods Enzymol; 2010; 485():459-80. PubMed ID: 21050932
[TBL] [Abstract][Full Text] [Related]
13. Generation of designer receptors exclusively activated by designer drugs (DREADDs) using directed molecular evolution.
Pei Y; Dong S; Roth BL
Curr Protoc Neurosci; 2010 Jan; Chapter 4():Unit 4.33. PubMed ID: 20066658
[TBL] [Abstract][Full Text] [Related]
14. Novel roles for arrestins in G protein-coupled receptor biology and drug discovery.
Claing A; Laporte SA
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):585-9. PubMed ID: 16159020
[TBL] [Abstract][Full Text] [Related]
15. Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs.
Dong S; Rogan SC; Roth BL
Nat Protoc; 2010 Mar; 5(3):561-73. PubMed ID: 20203671
[TBL] [Abstract][Full Text] [Related]
16. Engineered GPCRs as tools to modulate signal transduction.
Pei Y; Rogan SC; Yan F; Roth BL
Physiology (Bethesda); 2008 Dec; 23():313-21. PubMed ID: 19074739
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptors: abnormalities in signal transmission, disease states and pharmacotherapy.
Zalewska M; Siara M; Sajewicz W
Acta Pol Pharm; 2014; 71(2):229-43. PubMed ID: 25272642
[TBL] [Abstract][Full Text] [Related]
18. DREADD: a chemogenetic GPCR signaling platform.
Zhu H; Roth BL
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25522378
[TBL] [Abstract][Full Text] [Related]
19. Light- and drug-activated G-protein-coupled receptors to control intracellular signalling.
Masseck OA; Rubelowski JM; Spoida K; Herlitze S
Exp Physiol; 2011 Jan; 96(1):51-6. PubMed ID: 21041315
[TBL] [Abstract][Full Text] [Related]
20. New roles for Galpha and RGS proteins: communication continues despite pulling sisters apart.
Wilkie TM; Kinch L
Curr Biol; 2005 Oct; 15(20):R843-54. PubMed ID: 16243026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
